Development and validation of a recurrent Clostridium difficile risk-prediction model.

Marya D Zilberberg1, Kimberly Reske, Margaret Olsen

  • 1EviMed Research Group, LLC, Goshen, Massachusetts; School of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts.

Summary

Identifying patients at high risk for recurrent Clostridium difficile infection (rCDI) at initial CDI (iCDI) onset is crucial. A predictive model identified key factors including healthcare-associated onset, prior hospitalizations, and specific medication use.

Related Concept Videos